Drugs & Therapy Perspectives

, Volume 34, Issue 6, pp 253–257 | Cite as

Treat gestational diabetes with insulin and/or oral antidiabetic agents when lifestyle changes are not effective

  • Adis Medical Writers
Disease Management


Treatment of gestational diabetes is important to achieve glycaemic control and reduce the risk of fetal and maternal complications. If nutritional therapy and/or physical activity are ineffective, treatment with insulin is usually recommended. Although metformin and glyburide (glibenclamide) are effective oral antidiabetics, their benefits and risks in treatment gestational diabetes should be carefully considered, as both agents cross the placenta and data on their long-term safety in pregnant women and fetuses are lacking.


Compliance with ethical standards

Conflict of interest

The article was adapted from Drugs 2017;77(16):1723–32 [2] by employees of Adis/Springer, who are responsible for the article content and declare no conflicts of interest.


The preparation of this review was not supported by any external funding.


  1. 1.
    Jovanovic L, Pettitt DJ. Gestational diabetes mellitus. JAMA. 2001;286(20):2516–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Mukerji G, Feig DS. Pharmacological management of gestational diabetes mellitus. Drugs. 2017;77(16):1723–32.CrossRefPubMedGoogle Scholar
  3. 3.
    Hapo Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.CrossRefGoogle Scholar
  4. 4.
    Guidelines Canadian Diabetes Association Clinical Practice. Diabetes and pregnancy. Can J Diabetes. 2013;37(Suppl 1):S168–83.Google Scholar
  5. 5.
    American Diabetes Association. Management of diabetes in pregnancy. Diabetes Care. 2017;40(Suppl 1):S114–9.CrossRefGoogle Scholar
  6. 6.
    Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 190: gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):e49–64.CrossRefGoogle Scholar
  7. 7.
    Diabetes in pregnancy. management from preconception to the postnatal period. London: National Institute for Health and Care Excellence; 2015.Google Scholar
  8. 8.
    Pettitt DJ, Ospina P, Howard C, et al. Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus. Diabet Med. 2007;24(10):1129–35.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Lv S, Wang J, Xu Y. Safety of insulin analogs during pregnancy: a meta-analysis. Arch Gynecol Obstet. 2015;292(4):749–56.CrossRefPubMedGoogle Scholar
  10. 10.
    Herrera KM, Rosenn BM, Foroutan J, et al. Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes. Am J Obstet Gynecol. 2015;213(3):426.e1–7.CrossRefGoogle Scholar
  11. 11.
    Balsells M, García-Patterson A, Solà I, et al. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ. 2015;350:h102. Scholar
  12. 12.
    Song R, Chen L, Chen Y, et al. Comparison of glyburide and insulin in the management of gestational diabetes: a meta-analysis. PLoS One. 2017;12(8):e0182488. Scholar
  13. 13.
    Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358(19):2003–15.CrossRefPubMedGoogle Scholar
  14. 14.
    Ijäs H, Vääräsmäki M, Saarela T, et al. A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months. BJOG. 2015;122(7):994–1000.CrossRefPubMedGoogle Scholar
  15. 15.
    Wouldes TA, Battin M, Coast S, et al. Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes. Arch Dis Child Fetal Neonatal Ed. 2016;101:F488–93.CrossRefGoogle Scholar
  16. 16.
    Rowan JA, Rush EC, Obolonkin V, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care. 2011;34(10):2279–84.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.SpringerAucklandNew Zealand

Personalised recommendations